INTERCEPT PHARMACEUTICALS IN

CUSIP: 45845PAA6 Class: NOTE 3.250% 7/0

Russell Investments Group, Ltd.'s Holding History (CIK: 0001692234)

Note: Option positions (PUT/CALL) are excluded.

Q1 2023
Shares 3,384,000 Value ($000) $3,380 Avg Close Range
Q4 2022
Shares 2,323,000 Value ($000) $2,316 Avg Close Range
Q3 2022
Shares 1,910,000 Value ($000) $1,875 Avg Close Range
Q2 2022
Shares 1,590,000 Value ($000) $1,579 Avg Close Range
Q1 2022
Shares 1,543,000 Value ($000) $1,433 Avg Close Range
Q4 2021
Shares 1,506,000 Value ($000) $1,451 Avg Close Range
Q3 2020
Shares 2,007,000 Value ($000) $1,613 Avg Close Range
Q2 2020
Shares 3,752,000 Value ($000) $2,823 Avg Close Range
Q1 2020
Shares 1,650,000 Value ($000) $1,320 Avg Close Range
Q4 2019
Shares 858,000 Value ($000) $865 Avg Close Range
Q1 2019
Shares 223,000 Value ($000) $221 Avg Close Range
Q4 2018
Shares 329,000 Value ($000) $303 Avg Close Range
Q3 2018
Shares 679,000 Value ($000) $686 Avg Close Range
Q2 2018
Shares 1,164,000 Value ($000) $1,019 Avg Close Range
Q1 2018
Shares 2,200,000 Value ($000) $1,763 Avg Close Range
Q4 2017
Shares 950,000 Value ($000) $767 Avg Close Range
Q3 2017
Shares 730,000 Value ($000) $566 Avg Close Range
Q2 2017
Shares 730,000 Value ($000) $712 Avg Close Range
Q1 2017
Shares 780,000 Value ($000) $729 Avg Close Range
Q4 2016
Shares 780,000 Value ($000) $700 Avg Close Range